Analyst firms · Stifel · ALXO
Stifel ALXO price target and rating history
ALX Oncology Holdings Inc. (ALXO) · Health Care
Stifel rates ALX Oncology Holdings Inc. (ALXO) Hold with a $14 price target, as of its latest action on Mar 8, 2024. It has published 3 rating actions on ALXO since September 2021, including 0 upgrades and 1 downgrade. Across 3 firms with a ALXO price target in the last 12 months, the median target is $5.
- Current rating
- Hold
- Price target
- $14
- Median target, all firms
- $5
- Actions on ALXO
- 3
Stifel price target on ALXO
Every Stifel rating on ALXO
- Mar 8, 2024
- Mar 1, 2022
- Sep 30, 2021
How other firms rate ALXO
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wells Fargo | Overweight | $5 | Mar 19, 2026 |
| UBS | Buy | $6 | Mar 6, 2026 |
| Jefferies | Buy | $4 | Nov 13, 2025 |
Questions about Stifel and ALXO
- What is Stifel's price target for ALXO?
- Stifel's latest stated price target for ALX Oncology Holdings Inc. (ALXO) is $14, from its action on Mar 8, 2024.
- What is Stifel's rating on ALXO?
- Stifel rates ALXO Hold, a neutral rating, as of Mar 8, 2024.
- When did Stifel last change its view on ALXO?
- On Mar 8, 2024, Stifel downgrades to Hold from Buy, price target $10 to $14.
- How does Stifel's ALXO target compare with other analysts?
- Across 3 firms with a ALXO price target in the last 12 months, the median target is $5.
More ALXO rating histories
All Stifel ratingsALXO news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.